Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Mochida Abandons Antidepressant MD-120, Lexapro’s Pediatric Use
February 7, 2023
- Astellas’ April-December Sales Up 17% on FX Tailwind; Xtandi Slows in US but Brisk in Japan
February 7, 2023
- Eisai’s 9-Month Profits Sink after One-Time BMS Alliance Gain a Year Ago
February 7, 2023
- Opdivo Extends Streak of Top-Seller Crown to 13 Months: Encise
February 7, 2023
- Astellas EVP Okamura to Become CEO in April
February 6, 2023
- Mitsubishi Chemical Calls It Quit for Medicago, COVID Jab
February 6, 2023
- Takeda Logs Double-Digit Growth, Led by Core Products and Weaker Yen
February 3, 2023
- Nobelpharma’s Nobelzin Granules Now Available, 2 Years after Approval
February 3, 2023
- Takeda Joins Pilot Study of Robotic Drug Delivery Service in Tokyo
February 3, 2023
- Roche/Chugai Drop Gantenerumab Alzheimer’s Program
February 3, 2023
- Chugai’s Sales Hit 1-Trillion-Yen Mark in 2022 on New Launches, Ronapreve
February 3, 2023
- Tarlige Snatches Pole Position from Twymeeg in GP Promotion Ranking in December: Intage
February 2, 2023
- Hemlibra Approved in Europe for Moderate Hemophilia A: Roche/Chugai
February 2, 2023
- Daiichi Sankyo’s Revenue Up 16.9% in April-December on Buoyant Mainstays
February 1, 2023
- Sumitomo Suffers 18.5 Billion Yen Net Loss in April-December on Kynmobi Woes
February 1, 2023
- Ono’s 9-Month Revenue Climbs 25% on Robust Opdivo and Forxiga Sales
February 1, 2023
- Jardiance Filed in Japan for Chronic Kidney Disease: BI/Lilly
February 1, 2023
- Daiichi Sankyo Taps CFO Okuzawa as New President, Set to Continue ADC Drive
February 1, 2023
- Boehringer Ingelheim in AMD Collab with Jichi Medical University
January 31, 2023
- BMS, Kyoto University Join Hands to Deliver Innovative Drugs
January 31, 2023
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…